InvestorsHub Logo

wimuskyfisherman

10/17/17 11:59 AM

#30771 RE: doogdilinger #30764

Doog,

How can IPCI management justify these things:

1. Regabatin not moving forward at all. Pfizer just got their drug approved and IPCI has not done anything. Nothing.... But keep pumping it as part of pipeline... When it is NOTHING! The only saving grace is Pfizer did not get approval for Fybromyalgia.
2. Inability to partner/monetize approved products. Yet take $1M bonus' for each one. Sad... Sad... Sad... Probably bought a new Lambo with the money.
3. Inability to partner pipeline.
4. ANDA approvals that were not approved because the FDA issued CRLs or asked for more info. Truth be told, these non approvals were at least 50% IPCI's fault for incomplete/poor applications. And IPCI's slow response to the FDA's new requests.
5. The Odidi's draw about $1.5M in salary annually. That is more than 10% of IPCI's total yearly expenses. How can they justify these large payouts when the company has floundered for many years... How much is $1.5M as a % of IPCI's pathetic market cap? Answer: way too much!

Now you know I have supported the same people I am bashing now. But enough is enough and something needs to be done. Wake up Odidi!